Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference25 articles.
1. Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: a Systematic Review and Meta-Analysis;Nast;J. Invest. Dermatol.,2015
2. Biologic fatigue in psoriasis;Levin;J Dermatolog Treat,2014
3. Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris;Gniadecki;Br J Dermatol,2015
4. Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR);Menter;J Eur Acad Dermatol Venereol,2016
5. Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: a Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR);Warren;J. Invest. Dermatol.,2015
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Biologic Drug Survival in Pediatric Psoriasis: A Retro-Prospective Observational Study;Annals of the Russian academy of medical sciences;2024-01-22
2. The Best Psoriasis Medications Emerge;JAMA Dermatology;2024-01-01
3. Efficacy of tofacitinib in psoriatic arthritis: literature review and case report;Meditsinskiy sovet = Medical Council;2023-11-23
4. Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients;Rheumatology and Therapy;2023-09-27
5. Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis;Clinical Rheumatology;2023-09-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3